Collaboration and License Agreements - Madrigal Therapeutics Inc. (“Madrigal”) (Details) - USD ($) |
3 Months Ended | ||||
|---|---|---|---|---|---|
Jun. 02, 2026 |
Jun. 30, 2026 |
May 04, 2026 |
Sep. 30, 2025 |
Jun. 30, 2025 |
|
| Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] | |||||
| Contract assets | $ 10,231,000 | $ 0 | |||
| Contract liabilities included in deferred revenue, current | 94,596,000 | $ 2,399,000 | $ 22,979,000 | ||
| Madrigal | Madrigal Licensing Agreement | |||||
| Collaborative Arrangements And Noncollaborative Arrangement Transactions [Line Items] | |||||
| Initial transaction price | $ 25,000,000.0 | ||||
| Future potential milestone payments | $ 975,000,000.0 | ||||
| Fixed consideration | 25,000,000 | ||||
| Contract assets | 0 | ||||
| Contract liabilities included in deferred revenue, current | $ 0 |